Home | Welcome to Contract Pharma   
Last Updated Thursday, November 27 2014
Print

Financial Report: BioClinica 3Q



Published November 8, 2012
BioClinica

3Q Revenues: $24.9 million (+16%)

3Q Earnings: $542,000 (+51%)

YTD Revenues: $70.7 million (+15%)

YTD Earnings: $2.6 million (+57%)

Comments: Service revenues increased 16% to a record $19.2 million. Current backlog was $114.1 million, up 4% in the quarter. Mark L. Weinstein, president and chief executive officer of BioClinica said, “We are extremely pleased with our third quarter operating results, which included strong growth in service revenue and non-GAAP operating income and margin resulting from increased demand for both our eClinical and medical imaging offerings.”


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On